RecruitingPhase 1NCT07025018

Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 Mutations

Studying Embryonal tumor of neuroepithelial tissue

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hutchmed
Principal Investigator
Jinsong Wu
Huashan Hospital
Intervention
HMPL-306(drug)
Enrollment
52 target
Eligibility
18 years · All sexes
Timeline
20252027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07025018 on ClinicalTrials.gov

Other trials for Embryonal tumor of neuroepithelial tissue

Additional recruiting or active studies for the same condition.

See all trials for Embryonal tumor of neuroepithelial tissue

← Back to all trials